Логин: Пароль: ?
 
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное

 

 

 

 

 

 

 

Новости/Аналитика

Cannabis versus pharmacological drugs

08.10.2020

The use of the therapeutic properties of cannabis leads to a reduction in the use of anxiolytic, sedative and antipsychotic drugs.

The sale of flowers that are low in tetrahydrocannabinol and high in cannabidiol (CBD) leads to a decrease in the consumption of anxiolytic, sedative and antipsychotic drugs. These are the conclusions reached by the participants in a scientific study led by Vincenzo Carrieri by specialists from the Italian Magna Græcia University of Catanzaro, the German Research Institute for Future Labor (Forschungsinstitut zur Zukunft der Arbeit), and the Italian University of Padu (dell'Università di Padova) and the Dutch Erasmus School of Economics.

According to scientists, “the possibility of using technical hemp for a therapeutic purpose prompted patients to abandon traditional medicine in search of alternative methods of treating their ailments.” In particular, the possibility of using the therapeutic properties of cannabis leads to a reduction in the use of anxiolytic, sedative and antipsychotic drugs. the availability of the use of "green mass" of hemp with significant therapeutic properties is directly related to:

- a decrease in the supply of anxiolytics (anti-anxiety drugs) by 11.5%;

- a decrease in the number of sedatives used by 10%;

- reduction in the number of antipsychotics used by 4.8%.

The study authors argue that the impact of the availability of the therapeutic properties of cannabis on prescription drug sales was greatest three months after they hit the market and remained statistically significant for over six months.

The main conclusion of the study is that at the level of the regulatory framework, it is necessary to improve patient access to the therapeutic properties of the hemp plant. Those. it is necessary to make a transition from prescription drugs made using the therapeutic properties of cannabis to unregulated CBD therapy, using food, cosmetics, food / feed / dietary supplements as a drug. Patients should be given access to more effective treatments for existing diseases with therapeutic properties of cannabis that are not used in traditional medicine.

Commentary of experts of the Association "Ukrainian technical hemp"

Earlier studies published in the European Economic Review suggest that regulating the use of the therapeutic properties of cannabis leaves and inflorescences has helped to reduce the sale of psychoactive plants on the illegal market. In particular, the legal use of the leaves and inflorescences of a plant with significant therapeutic properties led to a 12% reduction in marijuana seizures from illicit trafficking, and the use of hashish decreased by 8%.

Потенциал национального рынка каннабиноидных косметических препаратов
17.01.2024

В Украине потребитель готов для выведения на рынок линейки национальной профессиональной CBD косметической продукции

Объявления
Все объявления »
 
 

facebook

telegram

twitter